Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix)
Filetype[PDF-2.41 MB]


  • Supporting Files:
    No Additional Files
    1. Evidence to recommendations framework for the use of Tdap for decennial Td booster, tetanus wound prophylaxis and the catch-up immunization schedule
      Personal Author:
      Havers, Fiona
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      June 26, 2019
      Series:
      ACIP meeting Pertussis Vaccines
      File Type:
      Filetype[PDF - 310.81 KB]
    2. Summary of HZ Work Group interpretation of RZV safety data
      Personal Author:
      Dooling, Kathleen
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      June 26, 2019
      Series:
      ACIP meeting Herpes Zoster Vaccine
      File Type:
      Filetype[PDF - 468.73 KB]
    3. Pertussis vaccines session
      Personal Author:
      Bernstein, Henry H.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      June 26, 2019
      Series:
      ACIP meeting Pertussis Vaccines
      File Type:
      Filetype[PDF - 288.56 KB]
    4. Herpes zoster vaccination update : introduction
      Personal Author:
      Moore, Kelly
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      June 26, 2019
      Series:
      ACIP meeting Herpes Zoster Vaccine
      File Type:
      Filetype[PDF - 432.52 KB]
You May Also Like:
  1. Shingles vaccination among adults aged 60 and over : United States, 2018
    Personal Author:
    Terlizzi, Emily P.; Black, Lindsey I.;
    Corporate Authors:
    National Center for Health Statistics (U.S.)
    Published Date:
     July 2020
    Series:
    NCHS data brief ; no. 370
    DHHS publication ; no. 2020–1209
    Description:
    Data from the National Health Interview Survey• Shingles vaccination among adults aged 60 and over increased from 6.7% in 2008 to 34.5% in 2018.• In 2018, women (35.4%) were equally as likely as men (33.5%) to have ever received a shingles vaccin...
    File Type:
    Filetype[PDF - 571.32 KB]
  2. Summary of HZ Work Group interpretation of RZV safety data
    Personal Author:
    Dooling, Kathleen
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
    Published Date:
    June 26, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    File Type:
    Filetype[PDF - 468.73 KB]
  3. Herpes zoster vaccination update : introduction
    Personal Author:
    Moore, Kelly
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
    Published Date:
    June 26, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    File Type:
    Filetype[PDF - 432.52 KB]
  4. Herpes zoster vaccination update : introduction
    Personal Author:
    Moore, Kelly L.
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Epidemiology and Prevention Branch. Influenza Surveillance and Outbreak Response Team.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    February 28, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Zoster-1-Moore-508.pdf
    File Type:
    Filetype[PDF - 436.51 KB]
  5. Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix)
    Personal Author:
    Shimabukuro, Tom T.
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    February 28, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Zoster-2-Shimabukuro-508.pdf
    File Type:
    Filetype[PDF - 2.25 MB]